Global 23-valent Pneumococcal Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Country/Region, 2017, 2022 & 2028

2.2 23-valent Pneumococcal Vaccine Segment by Type

2.2.1 Single Dose Vial

2.2.2 Pre-filled Syringe

2.3 23-valent Pneumococcal Vaccine Sales by Type

2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022)

2.4 23-valent Pneumococcal Vaccine Segment by Application

2.4.1 Chronic Cardiovascular Disease

2.4.2 Chronic Lung Disease

2.4.3 Chronic Liver Disease

2.4.4 People Living with Hiv

2.4.5 Leukemia

2.4.6 Lymphoma

2.4.7 Multiple Myeloma

2.4.8 General Malignancy

2.4.9 Chronic Kidney Disease

2.4.10 Other

2.5 23-valent Pneumococcal Vaccine Sales by Application

2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022)

3 Global 23-valent Pneumococcal Vaccine by Company

3.1 Global 23-valent Pneumococcal Vaccine Breakdown Data by Company

3.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)

3.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022)

3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company

3.4 Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution

3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for 23-valent Pneumococcal Vaccine by Geographic Region

4.1 World Historic 23-valent Pneumococcal Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Geographic Region

4.2 World Historic 23-valent Pneumococcal Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Country/Region

4.3 Americas 23-valent Pneumococcal Vaccine Sales Growth

4.4 APAC 23-valent Pneumococcal Vaccine Sales Growth

4.5 Europe 23-valent Pneumococcal Vaccine Sales Growth

4.6 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth

5 Americas

5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country

5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)

5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)

5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type

5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region

6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022)

6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022)

6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type

6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe 23-valent Pneumococcal Vaccine by Country

7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)

7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)

7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type

7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country

8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type

8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine

10.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine

10.4 Industry Chain Structure of 23-valent Pneumococcal Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 23-valent Pneumococcal Vaccine Distributors

11.3 23-valent Pneumococcal Vaccine Customer

12 World Forecast Review for 23-valent Pneumococcal Vaccine by Geographic Region

12.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region

12.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Region (2023-2028)

12.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global 23-valent Pneumococcal Vaccine Forecast by Type

12.7 Global 23-valent Pneumococcal Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck 23-valent Pneumococcal Vaccine Product Offered

13.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Sanofipasteur

13.2.1 Sanofipasteur Company Information

13.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered

13.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofipasteur Main Business Overview

13.2.5 Sanofipasteur Latest Developments

13.3 CDIBP

13.3.1 CDIBP Company Information

13.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Offered

13.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CDIBP Main Business Overview

13.3.5 CDIBP Latest Developments

13.4 Kexing Bio

13.4.1 Kexing Bio Company Information

13.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Offered

13.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Kexing Bio Main Business Overview

13.4.5 Kexing Bio Latest Developments

13.5 Changsheng Bio-Technology

13.5.1 Changsheng Bio-Technology Company Information

13.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered

13.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Changsheng Bio-Technology Main Business Overview

13.5.5 Changsheng Bio-Technology Latest Developments

13.6 Huaan Science and Technology Innovation

13.6.1 Huaan Science and Technology Innovation Company Information

13.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered

13.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Huaan Science and Technology Innovation Main Business Overview

13.6.5 Huaan Science and Technology Innovation Latest Developments

14 Research Findings and Conclusion

Table 1. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Single Dose Vial

Table 4. Major Players of Pre-filled Syringe

Table 5. Global 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global 23-valent Pneumococcal Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global 23-valent Pneumococcal Vaccine Revenue by Application (2017-2022)

Table 13. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global 23-valent Pneumococcal Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area

Table 21. Players 23-valent Pneumococcal Vaccine Products Offered

Table 22. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global 23-valent Pneumococcal Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global 23-valent Pneumococcal Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global 23-valent Pneumococcal Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global 23-valent Pneumococcal Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global 23-valent Pneumococcal Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global 23-valent Pneumococcal Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of 23-valent Pneumococcal Vaccine

Table 66. Key Market Challenges & Risks of 23-valent Pneumococcal Vaccine

Table 67. Key Industry Trends of 23-valent Pneumococcal Vaccine

Table 68. 23-valent Pneumococcal Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. 23-valent Pneumococcal Vaccine Distributors List

Table 71. 23-valent Pneumococcal Vaccine Customer List

Table 72. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global 23-valent Pneumococcal Vaccine Sales Market Forecast by Region

Table 74. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck 23-valent Pneumococcal Vaccine Product Offered

Table 94. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered

Table 99. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Sanofipasteur Main Business

Table 101. Sanofipasteur Latest Developments

Table 102. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. CDIBP 23-valent Pneumococcal Vaccine Product Offered

Table 104. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. CDIBP Main Business

Table 106. CDIBP Latest Developments

Table 107. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Kexing Bio 23-valent Pneumococcal Vaccine Product Offered

Table 109. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Kexing Bio Main Business

Table 111. Kexing Bio Latest Developments

Table 112. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered

Table 114. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Changsheng Bio-Technology Main Business

Table 116. Changsheng Bio-Technology Latest Developments

Table 117. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered

Table 119. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Huaan Science and Technology Innovation Main Business

Table 121. Huaan Science and Technology Innovation Latest Developments

List of Figures

Figure 1. Picture of 23-valent Pneumococcal Vaccine

Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Single Dose Vial

Figure 10. Product Picture of Pre-filled Syringe

Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2021

Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease

Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2017-2022) & (K Units)

Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease

Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2017-2022) & (K Units)

Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease

Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2017-2022) & (K Units)

Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv

Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2017-2022) & (K Units)

Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia

Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2017-2022) & (K Units)

Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma

Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2017-2022) & (K Units)

Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma

Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2017-2022) & (K Units)

Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy

Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2017-2022) & (K Units)

Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease

Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2017-2022) & (K Units)

Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other

Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2017-2022) & (K Units)

Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)

Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2021

Figure 35. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 36. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2021

Figure 37. Global 23-valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2021

Figure 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)

Figure 40. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region in 2021

Figure 41. Americas 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)

Figure 42. Americas 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 43. APAC 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)

Figure 44. APAC 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 45. Europe 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)

Figure 46. Europe 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 47. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)

Figure 48. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021

Figure 50. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021

Figure 51. United States 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2021

Figure 56. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2021

Figure 57. China 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Korea 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. India 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021

Figure 64. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021

Figure 65. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. France 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. UK 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 69. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 70. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021

Figure 71. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021

Figure 72. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 73. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 74. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 75. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 76. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 77. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2021

Figure 78. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine

Figure 79. Industry Chain Structure of 23-valent Pneumococcal Vaccine

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles